ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL MAGUIRE M.D.

Psychiatry

14,496

$1.25M

413
32 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $122

PAUL FALLON M.D

Psychiatry

9,202

$1.02M

477
71 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $122

JANET CARELLA MD

Psychiatry

8,099

$1.3M

327
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$161
Average prescription price

Avg: $122

VLADIMIR JELNOV MD

Psychiatry

7,612

$826K

264
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$108
Average prescription price

Avg: $122

QUENTIN TURNBULL MD

Psychiatry

7,261

$771K

544
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$106
Average prescription price

Avg: $122

ELIZABETH BLENCOWE MD

Psychiatry

6,801

$860K

381
38 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $122

ALMOS NAGY M.D.

Psychiatry

6,115

$552K

523
172 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $122

EDWARD DRUMMOND MD

Psychiatry

5,942

$659K

241
29 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $122

MARIA GATICALES MD

Psychiatry

5,543

$422K

301
46 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $122

ANDREW MORRIS MD

Psychiatry

5,347

$953K

207
25 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $122

DARWYN CHERN MD

Psychiatry

5,165

$517K

371
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $122

HISHAM HAFEZ M.D.

Psychiatry

4,887

$978K

244
37 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$200
Average prescription price

Avg: $122

GABRIELE LIEBERG MD

Psychiatry

4,857

$729K

267
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$150
Average prescription price

Avg: $122

JWALANT VADALIA MD

Psychiatry

4,689

$418K

528
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $122

PHILIP SANTORA M.D.

Psychiatry

4,664

$392K

309
75 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $122

KEVIN DICESARE MD

Psychiatry

3,722

$569K

317
42 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$153
Average prescription price

Avg: $122

OSVALDO EVANGELISTA MD

Psychiatry

3,320

$457K

300
115 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $122

GWENDOLYN BARROS MD

Psychiatry

3,052

$452K

212
21 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $122

ROBERT MURRAY MD

Psychiatry

2,982

$428K

177
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $122

JAMES KATES MD

Psychiatry

2,822

$326K

226
51 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$116
Average prescription price

Avg: $122

CLAIRE WENDLING MD

Psychiatry

2,780

$375K

204
18 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $122

ERINN FELLNER M.D.

Psychiatry

2,633

$334K

152
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $122

ELIZABETH MEADOW M.D.

Psychiatry

2,630

$227K

34
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $122

MARIANNE MARSH MD

Psychiatry

2,564

$270K

221
17 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $122

PAUL LIDSTROM MD

Psychiatry

2,564

$368K

125
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 2%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $122

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank